Assessing the effectiveness and cost-effectiveness of audit and feedback on physician’s prescribing indicators: study protocol of a randomized controlled trial with economic evaluation

BackgroundPhysician prescribing is the most frequent medical intervention with a highest impact on healthcare costs and outcomes. Therefore improving and promoting rational drug use is a great interest. We aimed to assess the effectiveness and cost-effectiveness of two forms of conducting prescribing audit and feedback interventions and a printed educational material intervention in improving physician prescribing.Method/designA four-arm randomized trial with economic evaluation will be conducted in Tehran. Three interventions (routine feedback, revised feedback, and printed educational material) and a no intervention control arm will be compared. Physicians working in outpatient practices are randomly allocated to one of the four arms using stratified randomized sampling. The interventions are developed based on a review of literature, physician interviews, current experiences in Iran and with theoretical insights from the Theory of Planned Behavior. Effects of the interventions on improving antibiotics and corticosteroids prescribing will be assessed in regression analyses. Cost data will be assessed from a health care provider’s perspective and incremental cost-effectiveness ratios will be calculated.DiscussionThis study will determine the effectiveness and cost-effectiveness of three interventions and allow us to determine the most effective interventions in improving prescribing pattern. If the interventions are cost-effective, they will likely be applied nationwide.Trial registrationIranian Registry of Clinical Trials Registration Number: IRCT201106086740N1Pharmaceutical Sciences Research Center of TUMS Ethics Committee Registration Number: 90-02-27-07

[1]  H. Hogerzeil,et al.  Promoting rational prescribing: an international perspective. , 1995, British journal of clinical pharmacology.

[2]  R. Grol,et al.  Implementing guidelines and innovations in general practice: which interventions are effective? , 1998, The British journal of general practice : the journal of the Royal College of General Practitioners.

[3]  Rassoul Dinarvand,et al.  CHALLENGES AND ACHIEVEMENTS OF PROMOTING RATIONAL USE OF DRUGS IN IRAN , 2009 .

[4]  N. Freemantle,et al.  Lessons from international experience in controlling pharmaceutical expenditure. I: influencing patients , 1996, BMJ.

[5]  I. Russell,et al.  Intentions and statins prescribing: can the theory of planned behaviour explain physician behaviour in following guideline recommendations? , 2011, Journal of evaluation in clinical practice.

[6]  J M Grimshaw,et al.  Effectiveness and efficiency of guideline dissemination and implementation strategies , 2004, International Journal of Technology Assessment in Health Care.

[7]  Arash Rashidian,et al.  General Practitioners’ Intentions and Prescribing for Asthma: Using the Theory of Planned Behavior to Explain Guideline Implementation , 2012, International journal of preventive medicine.

[8]  M. Pérez-Rodríguez,et al.  Effectiveness of the Combination of Feedback and Educational Recommendations for Improving Drug Prescription in General Practice , 2004, Medical care.

[9]  U. Goldbourt,et al.  Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?: A Systematic Review , 1998 .

[10]  Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[11]  P. Macfarlane,et al.  West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .

[12]  H. Rezazadeh,et al.  Effect of interactive group discussion among physicians to promote rational prescribing. , 2009, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[13]  A. Rashidian,et al.  Sample size for regression analyses of theory of planned behaviour studies: case of prescribing in general practice. , 2006, British journal of health psychology.

[14]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[15]  I. Ajzen The theory of planned behavior , 1991 .

[16]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.

[17]  Y. Behmanesh,et al.  Physicians` Attitude Toward Injectable Medicines , 2006 .

[18]  C. Silagy,et al.  Trials of providing costing information to general practitioners: a systematic review , 1997, The Medical journal of Australia.

[19]  J. Lexchin Improving the Appropriateness of Physician Prescribing , 1998, International journal of health services : planning, administration, evaluation.

[20]  B. Psaty,et al.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.

[21]  Jane M. Young,et al.  Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.

[22]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[23]  G. K. Chambers,et al.  Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[24]  N. Freemantle,et al.  Fortnightly Review: Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors , 1996, BMJ.

[25]  J. Grimshaw,et al.  Printed educational materials: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.

[26]  N Freemantle,et al.  Printed educational materials: effects on professional practice and health care outcomes. , 2000, The Cochrane database of systematic reviews.

[27]  M. Eccles,et al.  Falling on stony ground? A qualitative study of implementation of clinical guidelines' prescribing recommendations in primary care. , 2008, Health policy.

[28]  S. Nikfar,et al.  Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. , 2004, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[29]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[30]  Gholamreza-Sepehri,et al.  The quality of prescribing in general practice in Kerman, Iran. , 2005, International journal of health care quality assurance incorporating Leadership in health services.

[31]  R. Majdzadeh,et al.  Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran , 2005, BMC international health and human rights.

[32]  Elias Mossialos,et al.  Pharmaceutical Expenditure in Spain: Cost and Control , 2000, International journal of health services : planning, administration, evaluation.

[33]  Mohammad Abdollahi,et al.  Management Information System In Promoting Rational Drug Use , 2012 .